Before the meeting, FDAs own briefing documents reached the same conclusion for all seven substances: do not add them to the list
Diese Daten sind praeliminar und stammen aus bioinformatischen Analysen, bilden aber die Grundlage fuer weiterfuehrende in-vivo-Studien
No study established a maximum safe duration
During his confirmation hearing, Kennedy name-checked Frances Oldham Kelsey, the FDA official who refused to approve thalidomide in the U.S., as an example of how scientists must follow the data and question science
Archived from the original on September 30, 2007
pylori infection or chronic atrophic gastritis to be associated with adverse cardiovascular events, including myocardial infarction and stroke (reviewed in 23-25)